Commercial strategy calibrated for innovators building solutions for cardio-kidney-metabolic health.
What We Do.
Dadson Advisory partners with companies building innovative technologies- devices, drugs, diagnostics, software or combination products- that address one or several aspects of cardiovascular-kidney-metabolic syndrome (CKM), the clinical interplay of heart disease, chronic kidney disease, type 2 diabetes, and obesity.
Care models, healthcare budgets and buying decisions that have long been built around four individual diseases are rapidly evolving to align with new clinical guidelines that essentially treat them as one chronic condition. Strategies employed to launch and scale innovation addressing CKM must be equally agile.
Dadson Advisory employs strategic foresight both to calibrate and extend the line-of-sight of core strategy building blocks, such as market segmentation, stakeholder mapping, value proposition development, financial modelling, channel selection/mix and commercial operational design.
The outcome is disciplined, reasoned planning for a commercial future yet to happen, made tangible & compelling enough to fund and build.
About the Principal.
Jed Dadson founded Dadson Advisory to devote more attention to the unique commercial challenges stemming from the convergence of chronic kidney disease, heart disease, type 2 diabetes and obesity.
He has spent more than twenty years in the Kidney space as a marketer, commercial strategist and business unit leader, collaborating with patients, physicians, care system stakeholders, and innovation teams to introduce technologies to help those with kidney disease. Most recently, Jed led global marketing for Medtronic's home dialysis portfolio and its Mozarc Medical spin-off, building the commercial case for home-based technologies still in development.
Jed studied Human Biology & Environmental Studies at The University of Toronto, followed by Marketing & Competitive Strategy at Northwestern’s Kellogg School of Management. An active member of Canada’s Life Sciences community, Jed sits on the board of Advancing Black Talent in Pharma, and was recognised by the Kidney Foundation of Canada for leadership in philanthropy.
Jed lives in Toronto, Canada along with his partner and two children.